Immvira Bioscience receives $8 million in strategic investment
Immvira Bioscience is an anti-tumor drug carrier developer in Cayman. It is mainly engaged in the clinical research and development of carrier technology as a potential cancer therapy. It is committed to developing original anti-tumor drug carriers through the drug’s own anti-tumor mechanism and tumor microenvironment improvement, including replication and non-replicating herpesvirus vectors, exosome delivery […]
Immvira Bioscience receives $8 million in strategic investment Read More »